AQR Capital Management
TCRT icon

AQR Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

AQR Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-419
Closed -$154K – 2160
2020
Q1 		$154K Hold
419
– – ﹤0.01% 1908
2019
Q4 		$297K Buy
419
+88
+27% +$60.6K ﹤0.01% 1912
2019
Q3 		$212K Buy
+331
New +$263K ﹤0.01% 1997
2016
Q2 		– Sell
-134
Closed -$149K – 2258
2016
Q1 		$149K Sell
134
-405
-75% -$414K ﹤0.01% 2147
2015
Q4 		$671K Sell
539
-194
-26% -$321K ﹤0.01% 1746
2015
Q3 		$990K Sell
733
-192
-21% -$317K ﹤0.01% 1433
2015
Q2 		$1.67M Buy
925
+529
+134% +$821K ﹤0.01% 1265
2015
Q1 		$640K Buy
+396
New +$587K ﹤0.01% 1605
2014
Q4 		– Sell
-847
Closed -$335K – 2621
2014
Q3 		$335K Buy
847
+14
+2% +$6.75K ﹤0.01% 2124
2014
Q2 		$503K Buy
833
+653
+363% +$364K ﹤0.01% 1977
2014
Q1 		$124K Sell
180
-2
-1% -$1.34K ﹤0.01% 2498
2013
Q4 		$118K Hold
182
– – ﹤0.01% 2503
2013
Q3 		$108K Hold
182
– – ﹤0.01% 2421
2013
Q2 		$57K Buy
+182
New +$50.5K ﹤0.01% 2311

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management's TCRT Position: Q2 2020 in Review

AQR Capital Management sold out of Alaunos Therapeutics (TCRT) in Q2 2020, closing a stake of 419 shares — an estimated $154K sold.

AQR Capital Management first reported a position in TCRT in Q2 2013 and held it in 14 quarters. The position peaked at $1.67M in Q2 2015. 146 funds tracked by Wall St. Rank hold TCRT as of Q2 2020.

  • AQR Capital Management reported no remaining Alaunos Therapeutics position as of Q2 2020 after selling out during the quarter.
  • AQR Capital Management sold 419 Alaunos Therapeutics shares in Q2 2020, an estimated $154K.
  • AQR Capital Management first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 14 quarters.
  • AQR Capital Management's Alaunos Therapeutics position peaked at $1.67M in Q2 2015.
  • 146 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2020.

Based on AQR Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.